Credit: Getty Images. Shionogi has announced positive results from the phase 3 APEKS-NP trial of cefiderocol (S-649266) for the treatment of nosocomial pneumonia. Shionogi has announced positive ...
U.S. Trade Representative Jamieson Greer on Friday said his office would initiate several new investigations under Section 301 of the Trade Act of 1974, covering most major trading partners and areas ...
In a study, IV fosfomycin appeared less effective than IV ceftriaxone or meropenem for bacteremic UTI caused by multidrug-resistant E. coli, but the drug may be considered for selected patients with ...
Amneal Biosciences announced the launch of Meropenem for Injection, the generic version of AstraZeneca's Merrem. The bactericidal activity of meropenem results from the inhibition of cell wall ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results